Recent studies highlight the critical role of ANXA2 as a pivotal regulator in the pathogenesis and progression of various liver diseases, including NAFLD and HCC (38, 39). This evidence concerns the gene ANXA2 and metabolic dysfunction-associated steatotic liver disease.